Refine
Has Fulltext
- yes (55)
Is part of the Bibliography
- yes (55)
Year of publication
Document Type
- Journal article (55) (remove)
Language
- English (55) (remove)
Keywords
- blood vessel (3)
- cancer (3)
- inflammation (3)
- organoid (3)
- TGFβ signaling (2)
- angiogenesis (2)
- diabetic retinopathy (2)
- expression (2)
- extracellular matrix (2)
- in vitro (2)
- macrophages (2)
- medical research (2)
- mouse (2)
- mucoepidermoid carcinoma (2)
- multiple sclerosis (2)
- neurotrophins (2)
- organoids (2)
- oxidative stress (2)
- photon-counting (2)
- pleomorphic adenoma (2)
- preclinical research (2)
- retinitis pigmentosa (2)
- translational research (2)
- tumor microenvironment (2)
- vasculogenesis (2)
- 18F-FDG (1)
- 3D image analysis (1)
- A549 cell line (1)
- AZD4547 (1)
- B cells (1)
- CEA (1)
- CEACAM1 (1)
- CMV (1)
- COPD (1)
- CT angiography (1)
- CXCL12-abundant reticular (CAR)-cells (1)
- Cancellous bone (1)
- Cancer models (1)
- Cancer therapeutic resistance (1)
- Chirurgie (1)
- Cone-beam computed tomography (1)
- DNA methylation (1)
- Developmental biology (1)
- EBV (1)
- ECM (1)
- EEOS (1)
- ELISPOT (1)
- ER-Stress (1)
- Elbow (1)
- Elbow joint (1)
- Endoplasmic-Reticulum Stress (1)
- FGFR signaling (1)
- Hematopoietic Stem (1)
- Heme-regulated inhibitor (1)
- Human Muse Cells (1)
- II type-2 receptor (1)
- IL6 (1)
- MAP kinase pathway (1)
- MS (1)
- Messenger-RNAs (1)
- Multidetector computed tomography (1)
- Mycobacterium tuberculosis (1)
- Myokarditis (1)
- NF-kappa-B (1)
- Neural Differentiation (1)
- OXPHOS (1)
- PET (1)
- PIK3R1 (1)
- Quality-control (1)
- ROS (1)
- Rv3034c (1)
- SARS-CoV-2 (1)
- SP-fixation (1)
- Stem cells (1)
- TNF-α (1)
- TTS (1)
- Targeted therapies (1)
- Transcription factor NRF1 (1)
- Translation Initiation (1)
- Tumour angiogenesis (1)
- VEGF (1)
- VPP mouse model (1)
- X-ray computed (1)
- abdominal imaging (1)
- acetyltransferase (1)
- acinic cell carcinoma (1)
- adenoid cystic carcinoma (ACC) (1)
- adhesion molecule-1 (1)
- adipose tissue (1)
- adipose-derived stromal cells (1)
- adventitia (1)
- age-related macular degeneration (1)
- aging (1)
- anatomy (1)
- angiotensin II (1)
- animal models (1)
- anti‐aging (1)
- aorta ring (1)
- aortic adventitia (1)
- assembloid (1)
- autoimmunity (1)
- beta-aminopropionitrile (1)
- biliary glycoprotein CD66A (1)
- bioprinting (1)
- blood pressure (1)
- bone (1)
- bone marrow-derived monocytes (1)
- brain-retina axis (1)
- breast cancer cells (1)
- breast cancer model (1)
- cable-clamp implants (1)
- cadaver multiorgan preservation (1)
- cancellous bone (1)
- cancer therapy (1)
- carcinoembryonic anitgen family (1)
- cardiac hyperthrophy (1)
- cardiovascular MRI (1)
- cell biology (1)
- chemotherapy (CH) (1)
- chromatin (1)
- chronic kidney disease (1)
- computed tomography angiography (CTA) (1)
- continuous extracorporeal femoral perfusion model (1)
- contractility (1)
- convolution kernel (1)
- cytokines (1)
- developmental biology (1)
- diabetes mellitus (1)
- diabetic nephropathy (1)
- diagnostic markers (1)
- differential expression (1)
- digital subtraction angiography (DSA) (1)
- dilated cardiomyopathy with ataxia (1)
- dovitinib (1)
- drug transport (1)
- editorial (1)
- electron microscopy (1)
- emphysema (1)
- endothelial cell infection (1)
- epithelial cells (1)
- epithelial salivary gland (1)
- experimental models of disease (1)
- extracellular matrix disorganisation (1)
- extracorporeal membrane oxygenation (1)
- extrusion of hiMPC-containing bioinks alginate + collagen type I (1)
- factor binding profiles (1)
- femoral arteries (1)
- ferroptosis (1)
- fracture (1)
- genetics (1)
- growth-factor (1)
- hACE2 (1)
- heart (1)
- heart failure (1)
- heart-brain axis (1)
- hematopoietic (1)
- high contrast (1)
- histone H1 (1)
- homebox genes (1)
- human endothelial cells (1)
- human iPSC-derived mesodermal cells (hiMPCs) (1)
- human induced pluripotent stem cells (1)
- human neurons (1)
- human osteosarcoma xenografts (1)
- hyaluronic acid (1)
- hypoxia (1)
- hypoxia inducible factor 1 (1)
- immunohistochemistry (1)
- immunotherapy (1)
- in-situ hybridization (1)
- induced neural stem cells (1)
- induced pluripotent stem cells (1)
- integrin α5β1 (1)
- integrin αvβ3 (1)
- intravascular ultrasound (IVUS) (1)
- ischemic stroke (1)
- large animal models (1)
- light sheet fluorescence microscopy (1)
- lipids (1)
- mRNA (1)
- malignancy (1)
- megakaryocytes (1)
- membrane vesicles (1)
- meninges (1)
- mesenchymal stem cells (1)
- mesenchymal stromal cells (1)
- mesodermal organoid (1)
- metabolism (1)
- metastasis (1)
- mice (1)
- microRNA (1)
- microglia (1)
- microvascular complications (1)
- microvasculature (1)
- mild hypothermia (1)
- mitochondria (1)
- molecular biology (1)
- multilayered vessel wall with intimate, media and adventitia (1)
- musculoskeletal system (1)
- mutations (1)
- myelin (1)
- myeloid (1)
- myocardial infarction (1)
- myocarditis (1)
- neural (1)
- neural crest (1)
- neural organoid (1)
- neuro-/photoreceptor degeneration (1)
- neurodegeneration (1)
- neuroimmunology (1)
- neuroinflammation (1)
- neuroprotective pathways (1)
- novel human cadaveric perfusion model (1)
- oligodendrocytes (1)
- open-access database (1)
- optical clearing (1)
- pancreatic cancer (1)
- parotid gland (1)
- peripheral nervous system (1)
- peroxisome (1)
- peroxisomes (1)
- personalized treatment (1)
- phosphatidylinositol (1)
- photon-counting computed tomography (CT) (1)
- pig (1)
- positron emission tomography (1)
- post-mortem heart recovery (1)
- probe level data (1)
- progenitor (1)
- progenitor cells (1)
- proliferation (1)
- pubic symphysis (1)
- pulmonary hypertension (1)
- radiation (1)
- radiotherapy (1)
- rat heart (1)
- reactive oxygen species (1)
- research infrastructure (1)
- resident CD34-positive cells (1)
- retina (1)
- salivary (1)
- salivary gland (1)
- salivary gland tumors (1)
- sasculature (1)
- sensory ganglia (1)
- sensory neuron (1)
- serial block face EM (1)
- signaling (1)
- small pixel effect (1)
- solid tumors (1)
- spectral shaping (1)
- spheroids (1)
- stroma (1)
- synapse (1)
- synaptic vesicles (1)
- tin prefiltration (1)
- tomography (1)
- transcapillary pressure gradient (1)
- transmission electron microscopy (1)
- tube formation (1)
- tumor (1)
- tumor spheroids (1)
- tumor-vessel wall-interface model (1)
- tumors (1)
- ultra-low-dose CT (1)
- ultrahigh resolution (1)
- ultrahigh-field MRI (1)
- urinary calculi (1)
- vascular biofabrication (1)
- vascular network and hierarchical organized vessels (1)
- vascular normalization (1)
- vascular structure (1)
- vascular wall stem and progenitor cells (1)
- vascularization model (1)
- vasculature (1)
- xerostomia (1)
Institute
- Institut für Anatomie und Zellbiologie (55)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (9)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (5)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (4)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (3)
- Medizinische Klinik und Poliklinik I (3)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (2)
- Graduate School of Life Sciences (2)
- Institut für Experimentelle Biomedizin (2)
- Institut für Pharmakologie und Toxikologie (2)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 701983 (1)
Ultra-high field cardiac MRI in large animals and humans for translational cardiovascular research
(2023)
A key step in translational cardiovascular research is the use of large animal models to better understand normal and abnormal physiology, to test drugs or interventions, or to perform studies which would be considered unethical in human subjects. Ultrahigh field magnetic resonance imaging (UHF-MRI) at 7 T field strength is becoming increasingly available for imaging of the heart and, when compared to clinically established field strengths, promises better image quality and image information content, more precise functional analysis, potentially new image contrasts, and as all in-vivo imaging techniques, a reduction of the number of animals per study because of the possibility to scan every animal repeatedly. We present here a solution to the dual use problem of whole-body UHF-MRI systems, which are typically installed in clinical environments, to both UHF-MRI in large animals and humans. Moreover, we provide evidence that in such a research infrastructure UHF-MRI, and ideally combined with a standard small-bore UHF-MRI system, can contribute to a variety of spatial scales in translational cardiovascular research: from cardiac organoids, Zebra fish and rodent hearts to large animal models such as pigs and humans. We present pilot data from serial CINE, late gadolinium enhancement, and susceptibility weighted UHF-MRI in a myocardial infarction model over eight weeks. In 14 pigs which were delivered from a breeding facility in a national SARS-CoV-2 hotspot, we found no infection in the incoming pigs. Human scanning using CINE and phase contrast flow measurements provided good image quality of the left and right ventricle. Agreement of functional analysis between CINE and phase contrast MRI was excellent. MRI in arrested hearts or excised vascular tissue for MRI-based histologic imaging, structural imaging of myofiber and vascular smooth muscle cell architecture using high-resolution diffusion tensor imaging, and UHF-MRI for monitoring free radicals as a surrogate for MRI of reactive oxygen species in studies of oxidative stress are demonstrated. We conclude that UHF-MRI has the potential to become an important precision imaging modality in translational cardiovascular research.
Blood vessel organoids are an important in vitro model to understand the underlying mechanisms of human blood vessel development and for toxicity testing or high throughput drug screening. Here we present a novel, cost-effective, and easy to manufacture vascular organoid model. To engineer the organoids, a defined number of human induced pluripotent stem cells are seeded in non-adhesive agarose coated wells of a 96-well plate and directed towards a lateral plate mesoderm fate by activation of Wnt and BMP4 signaling. We observe the formation of a circular layer of angioblasts around days 5–6. Induced by VEGF application, CD31\(^+\) vascular endothelial cells appear within this vasculogenic zone at approximately day 7 of organoid culture. These cells arrange to form a primitive vascular plexus from which angiogenic sprouting is observed after 10 days of culture. The differentiation outcome is highly reproducible, and the size of organoids is scalable depending on the number of starting cells. We observe that the initial vascular ring forms at the interface between two cell populations. The inner cellular compartment can be distinguished from the outer by the expression of GATA6, a marker of lateral plate mesoderm. Finally, 14-days-old organoids were transplanted on the chorioallantois membrane of chicken embryos resulting in a functional connection of the human vascular network to the chicken circulation. Perfusion of the vessels leads to vessel wall maturation and remodeling as indicated by the formation of a continuous layer of smooth muscle actin expressing cells enwrapping the endothelium. In summary, our organoid model recapitulates human vasculogenesis, angiogenesis as well as vessel wall maturation and therefore represents an easy and cost-effective tool to study all steps of blood vessel development and maturation directly in the human setting without animal experimentation.
Ischemic insults to the heart and brain, i.e., myocardial and cerebral infarction, respectively, are amongst the leading causes of death worldwide. While there are therapeutic options to allow reperfusion of ischemic myocardial and brain tissue by reopening obstructed vessels, mitigating primary tissue damage, post-infarction inflammation and tissue remodeling can lead to secondary tissue damage. Similarly, ischemia in retinal tissue is the driving force in the progression of neovascular eye diseases such as diabetic retinopathy (DR) and age-related macular degeneration (AMD), which eventually lead to functional blindness, if left untreated. Intriguingly, the easily observable retinal blood vessels can be used as a window to the heart and brain to allow judgement of microvascular damages in diseases such as diabetes or hypertension. The complex neuronal and endocrine interactions between heart, retina and brain have also been appreciated in myocardial infarction, ischemic stroke, and retinal diseases. To describe the intimate relationship between the individual tissues, we use the terms heart-brain and brain-retina axis in this review and focus on the role of transforming growth factor β (TGFβ) and neurotrophins in regulation of these axes under physiologic and pathologic conditions. Moreover, we particularly discuss their roles in inflammation and repair following ischemic/neovascular insults. As there is evidence that TGFβ signaling has the potential to regulate expression of neurotrophins, it is tempting to speculate, and is discussed here, that cross-talk between TGFβ and neurotrophin signaling protects cells from harmful and/or damaging events in the heart, retina, and brain.
B cell aggregates in the central nervous system (CNS) have been associated with rapid disease progression in patients with multiple sclerosis (MS). Here we demonstrate a key role of carcinoembryogenic antigen-related cell adhesion molecule1 (CEACAM1) in B cell aggregate formation in MS patients and a B cell-dependent mouse model of MS. CEACAM1 expression was increased on peripheral blood B cells and CEACAM1\(^+\) B cells were present in brain infiltrates of MS patients. Administration of the anti-CEACAM1 antibody T84.1 was efficient in blocking aggregation of B cells derived from MS patients. Along these lines, application of the monoclonal anti-CEACAM1 antibody mCC1 was able to inhibit CNS B cell aggregate formation and significantly attenuated established MS-like disease in mice in the absence of any adverse effects. CEACAM1 was co-expressed with the regulator molecule T cell immunoglobulin and mucin domain −3 (TIM-3) on B cells, a novel molecule that has recently been described to induce anergy in T cells. Interestingly, elevated coexpression on B cells coincided with an autoreactive T helper cell phenotype in MS patients. Overall, these data identify CEACAM1 as a clinically highly interesting target in MS pathogenesis and open new therapeutic avenues for the treatment of the disease.
LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy
(2018)
The potential of altering the tumor ECM to improve drug response remains fairly unexplored. To identify targets for modification of the ECM aiming to improve drug response and overcome resistance, we analyzed expression data sets from pre-treatment patient cohorts. Cross-evaluation identified a subset of chemoresistant tumors characterized by increased expression of collagens and collagen-stabilizing enzymes. We demonstrate that strong collagen expression and stabilization sets off a vicious circle of self-propagating hypoxia, malignant signaling, and aberrant angiogenesis that can be broken by an appropriate auxiliary intervention: Interfering with collagen stabilization by inhibition of lysyl oxidases significantly enhanced response to chemotherapy in various tumor models, even in metastatic disease. Inhibition of collagen stabilization by itself can reduce or enhance tumor growth depending on the tumor type. The mechanistical basis for this behavior is the dependence of the individual tumor on nutritional supply on one hand and on high tissue stiffness for FAK signaling on the other.
Summary
Here we describe a novel neuro-mesodermal assembloid model that recapitulates aspects of peripheral nervous system (PNS) development such as neural crest cell (NCC) induction, migration, and sensory as well as sympathetic ganglion formation. The ganglia send projections to the mesodermal as well as neural compartment. Axons in the mesodermal part are associated with Schwann cells. In addition, peripheral ganglia and nerve fibers interact with a co-developing vascular plexus, forming a neurovascular niche. Finally, developing sensory ganglia show response to capsaicin indicating their functionality.
The presented assembloid model could help to uncover mechanisms of human NCC induction, delamination, migration, and PNS development. Moreover, the model could be used for toxicity screenings or drug testing. The co-development of mesodermal and neuroectodermal tissues and a vascular plexus along with a PNS allows us to investigate the crosstalk between neuroectoderm and mesoderm and between peripheral neurons/neuroblasts and endothelial cells.
Highlights
•Novel neuro-mesodermal assembloid model of peripheral nervous system development
•Model covers neural crest cell induction, migration, and ganglion formation
•Ganglia send projections to the mesodermal as well as neural compartment
•Peripheral ganglia and nerve fibers interact with a co-developing vascular plexus
Fibroblast growth factor (FGF) signaling is involved in the pathogenesis of multiple sclerosis (MS). Data from neuropathology studies suggest that FGF signaling contributes to the failure of remyelination in MS. In MOG\(_{35–55}\)-induced EAE, oligodendrocyte-specific deletion of FGFR1 and FGFR2 resulted in a less severe disease course, reduced inflammation, myelin and axon degeneration and changed FGF/FGFR and BDNF/TrkB signaling. Since signaling cascades in oligodendrocytes could not be investigated in the EAE studies, we here aimed to characterize FGFR-dependent oligodendrocyte-specific signaling in vitro. FGFR inhibition was achieved by application of the multi-kinase-inhibitor dovitinib and the FGFR1/2/3-inhibitor AZD4547. Both substances are potent inhibitors of FGF signaling; they are effective in experimental tumor models and patients with malignancies. Effects of FGFR inhibition in oligodendrocytes were studied by immunofluorescence microscopy, protein and gene analyses. Application of the tyrosine kinase inhibitors reduced FGFR1, phosphorylated ERK and Akt expression, and it enhanced BDNF and TrkB expression. Furthermore, the myelin proteins CNPase and PLP were upregulated by FGFR inhibition. In summary, inhibition of FGFR signaling in oligodendrocytes can be achieved by application of tyrosine kinase inhibitors. Decreased phosphorylation of ERK and Akt is associated with an upregulation of BDNF/TrkB signaling, which may be responsible for the increased production of myelin proteins. Furthermore, these data suggest that application of FGFR inhibitors may have the potential to promote remyelination in the CNS.
Photon-counting detector (PCD) CT allows for ultra-high-resolution (UHR) examinations of the shoulder without requiring an additional post-patient comb filter to narrow the detector aperture. This study was designed to compare the PCD performance with a high-end energy-integrating detector (EID) CT. Sixteen cadaveric shoulders were examined with both scanners using dose-matched 120 kVp acquisition protocols (low-dose/full-dose: CTDI\(_{vol}\) = 5.0/10.0 mGy). Specimens were scanned in UHR mode with the PCD-CT, whereas EID-CT examinations were conducted in accordance with the clinical standard as “non-UHR”. Reconstruction of EID data employed the sharpest kernel available for standard-resolution scans (ρ\(_{50}\) = 12.3 lp/cm), while PCD data were reconstructed with both a comparable kernel (11.8 lp/cm) and a sharper dedicated bone kernel (16.5 lp/cm). Six radiologists with 2–9 years of experience in musculoskeletal imaging rated image quality subjectively. Interrater agreement was analyzed by calculation of the intraclass correlation coefficient in a two-way random effects model. Quantitative analyses comprised noise recording and calculating signal-to-noise ratios based on attenuation measurements in bone and soft tissue. Subjective image quality was higher in UHR-PCD-CT than in EID-CT and non-UHR-PCD-CT datasets (all p < 0.001). While low-dose UHR-PCD-CT was considered superior to full-dose non-UHR studies on either scanner (all p < 0.001), ratings of low-dose non-UHR-PCD-CT and full-dose EID-CT examinations did not differ (p > 0.99). Interrater reliability was moderate, indicated by a single measures intraclass correlation coefficient of 0.66 (95% confidence interval: 0.58–0.73; p < 0.001). Image noise was lowest and signal-to-noise ratios were highest in non-UHR-PCD-CT reconstructions at either dose level (p < 0.001). This investigation demonstrates that superior depiction of trabecular microstructure and considerable denoising can be realized without additional radiation dose by employing a PCD for shoulder CT imaging. Allowing for UHR scans without dose penalty, PCD-CT appears as a promising alternative to EID-CT for shoulder trauma assessment in clinical routine.
In this study, the impact of reconstruction sharpness on the visualization of the appendicular skeleton in ultrahigh-resolution (UHR) photon-counting detector (PCD) CT was investigated. Sixteen cadaveric extremities (eight fractured) were examined with a standardized 120 kVp scan protocol (CTDI\(_{vol}\) 10 mGy). Images were reconstructed with the sharpest non-UHR kernel (Br76) and all available UHR kernels (Br80 to Br96). Seven radiologists evaluated image quality and fracture assessability. Interrater agreement was assessed with the intraclass correlation coefficient. For quantitative comparisons, signal-to-noise-ratios (SNRs) were calculated. Subjective image quality was best for Br84 (median 1, interquartile range 1–3; p ≤ 0.003). Regarding fracture assessability, no significant difference was ascertained between Br76, Br80 and Br84 (p > 0.999), with inferior ratings for all sharper kernels (p < 0.001). Interrater agreement for image quality (0.795, 0.732–0.848; p < 0.001) and fracture assessability (0.880; 0.842–0.911; p < 0.001) was good. SNR was highest for Br76 (3.4, 3.0–3.9) with no significant difference to Br80 and Br84 (p > 0.999). Br76 and Br80 produced higher SNRs than all kernels sharper than Br84 (p ≤ 0.026). In conclusion, PCD-CT reconstructions with a moderate UHR kernel offer superior image quality for visualizing the appendicular skeleton. Fracture assessability benefits from sharp non-UHR and moderate UHR kernels, while ultra-sharp reconstructions incur augmented image noise.
Normal and malignant cells release a variety of different vesicles into their extracellular environment. The most prominent vesicles are the microvesicles (MVs, 100-1 000 nm in diameter), which are shed of the plasma membrane, and the exosomes (70-120 nm in diameter), derivates of the endosomal system. MVs have been associated with intercellular communication processes and transport numerous proteins, lipids and RNAs. As essential component of immune-escape mechanisms tumor-derived MVs suppress immune responses. Additionally, tumor-derived MVs have been found to promote metastasis, tumor-stroma interactions and angiogenesis. Since members of the carcinoembryonic antigen related cell adhesion molecule (CEACAM)-family have been associated with similar processes, we studied the distribution and function of CEACAMs in MV fractions of different human epithelial tumor cells and of human and murine endothelial cells. Here we demonstrate that in association to their cell surface phenotype, MVs released from different human epithelial tumor cells contain CEACAM1, CEACAM5 and CEACAM6, while human and murine endothelial cells were positive for CEACAM1 only. Furthermore, MVs derived from CEACAM1 transfected CHO cells carried CEACAM1. In terms of their secretion kinetics, we show that MVs are permanently released in low doses, which are extensively increased upon cellular starvation stress. Although CEACAM1 did not transmit signals into MVs it served as ligand for CEACAM expressing cell types. We gained evidence that CEACAM1-positive MVs significantly increase the CD3 and CD3/CD28-induced T-cell proliferation. All together, our data demonstrate that MV-bound forms of CEACAMs play important roles in intercellular communication processes, which can modulate immune response, tumor progression, metastasis and angiogenesis.